Prior optic neuritis detection on peripapillary ring scans using deep learning.

Journal: Annals of clinical and translational neurology
Published Date:

Abstract

BACKGROUND: The diagnosis of multiple sclerosis (MS) requires demyelinating events that are disseminated in time and space. Peripapillary retinal nerve fiber layer (pRNFL) thickness as measured by optical coherence tomography (OCT) distinguishes eyes with a prior history of acute optic neuritis (ON) and may provide evidence to support a demyelinating attack.

Authors

  • Seyedamirhosein Motamedi
    Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Sunil Kumar Yadav
    Nocturne GmbH, Berlin, Germany.
  • Rachel C Kenney
  • Ting-Yi Lin
    Department of Medical Research, Taipei Veterans General Hospital, Taipei 112201, Taiwan.
  • Josef Kauer-Bonin
    Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Hanna G Zimmermann
    Experimental and Clinical Research Center, a cooperation between the Max Delbrück Center for Molecular Medicine in the Helmholtz Association and Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Steven L Galetta
    Departments of Neurology, Population Health and Ophthalmology, New York University, New York, New York, USA.
  • Laura J Balcer
    Departments of Neurology, Population Health and Ophthalmology, New York University, New York, New York, USA.
  • Friedemann Paul
    Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Department of Neurology, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), NeuroCure Clinical Research Center, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universitt zu Berlin, Berlin Institute of Health (BIH), Experimental and Clinical Research Center, Max Delbrück Center for Molecular Medicine, 10117 Berlin, Germany; Einstein Center for Digital Future Berlin, Germany.
  • Alexander U Brandt
    Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), Department of Neurology, 10117 Berlin, Germany; Charité - Universitätsmedizin Berlin, Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin Institute of Health (BIH), NeuroCure Clinical Research Center, 10117 Berlin, Germany; Department of Neurology, University of California, Irvine, CA, USA.